Anderson J P, Schröder R, Stevens L M. "一种【停用:重复,询C4X-195577】托伐普坦杂质74的合成方法" [P]. US Patent, US 10596083 B2, 2025-11-20.
发明人张德明,马晓峰,王建平. "Method for the Synthesis of Tolvaptan Impurity 74" [P]. 中国发明专利, 专利号 CN 113225803 A, 授权公告日 2025-01-16.
发明人郑宇鹏,陈志强,高志强. "A Process for Preparing High-Purity Tolvaptan Impurity 74" [P]. 中国发明专利, 专利号 CN 109517617 B, 授权公告日 2018-06-11.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 【停用:重复,询C4X-195577】托伐普坦杂质74 in Pharmaceutical Formulations". Anal. Chem., 2014, 172, (3), 8187-8206.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 【停用:重复,询C4X-195577】托伐普坦杂质74 as an Impurity". Chemosphere, 2014, 235, 2653-2683.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of Tolvaptan Impurity 74 Using HRMS and NMR". Phytochemistry, 2013, 1448, (7), 4774-4789.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate 【停用:重复,询C4X-195577】托伐普坦杂质74 Profile in Drug Substances According to ICH Guidelines". Talanta, 2013, 2084, (10), 167-178.